吡啶-3-基)咪唑并[2,1-b][1,3,4]噻二唑与 1,3,4-恶二唑连接的酰胺衍生物的合理设计、合成和抗癌评估

IF 2.218 Q2 Chemistry
Khasim Saheb Shaik , Saritha N , Nagendra Reddy G
{"title":"吡啶-3-基)咪唑并[2,1-b][1,3,4]噻二唑与 1,3,4-恶二唑连接的酰胺衍生物的合理设计、合成和抗癌评估","authors":"Khasim Saheb Shaik ,&nbsp;Saritha N ,&nbsp;Nagendra Reddy G","doi":"10.1016/j.cdc.2024.101147","DOIUrl":null,"url":null,"abstract":"<div><p>A new series of amides of pyridin-3-yl)imidazo[2,1-b][1,3,4]thiadiazoles (<strong>13a-j</strong>) have been developed and confirmed by <sup>1</sup>HNMR, <sup>13</sup>CNMR and mass spectral data. Further, in the vitro anticancer activity of newly prepared compounds <strong>13a-j</strong> was examined against four human cancer cell lines including MCF-7 &amp; MDA MB-231 (human breast cancer), A549 (human lung cancer) and DU-145 (human prostate cancer) by employing the MTT assay, and using etoposide as a standard reference. These results indicated that the most of the derivatives displayed excellent to moderate anticancer activity. Among the five compounds <strong>13a, 13b, 13c, 13d</strong> and <strong>13e</strong> demonstrated remarkable activity as standard. One of the compounds <strong>13a</strong> displayed excellent activity.</p></div>","PeriodicalId":269,"journal":{"name":"Chemical Data Collections","volume":"52 ","pages":"Article 101147"},"PeriodicalIF":2.2180,"publicationDate":"2024-06-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Rational design, synthesis, and anticancer evaluation of amide derivatives of Pyridin3-yl)imidazo[2,1-b][1,3,4]thiadiazole linked 1,3,4-oxadiazoles\",\"authors\":\"Khasim Saheb Shaik ,&nbsp;Saritha N ,&nbsp;Nagendra Reddy G\",\"doi\":\"10.1016/j.cdc.2024.101147\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>A new series of amides of pyridin-3-yl)imidazo[2,1-b][1,3,4]thiadiazoles (<strong>13a-j</strong>) have been developed and confirmed by <sup>1</sup>HNMR, <sup>13</sup>CNMR and mass spectral data. Further, in the vitro anticancer activity of newly prepared compounds <strong>13a-j</strong> was examined against four human cancer cell lines including MCF-7 &amp; MDA MB-231 (human breast cancer), A549 (human lung cancer) and DU-145 (human prostate cancer) by employing the MTT assay, and using etoposide as a standard reference. These results indicated that the most of the derivatives displayed excellent to moderate anticancer activity. Among the five compounds <strong>13a, 13b, 13c, 13d</strong> and <strong>13e</strong> demonstrated remarkable activity as standard. One of the compounds <strong>13a</strong> displayed excellent activity.</p></div>\",\"PeriodicalId\":269,\"journal\":{\"name\":\"Chemical Data Collections\",\"volume\":\"52 \",\"pages\":\"Article 101147\"},\"PeriodicalIF\":2.2180,\"publicationDate\":\"2024-06-02\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Chemical Data Collections\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2405830024000351\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"Chemistry\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Chemical Data Collections","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2405830024000351","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Chemistry","Score":null,"Total":0}
引用次数: 0

摘要

研究人员开发了一系列新的吡啶-3-基)咪唑并[2,1-b][1,3,4]噻二唑酰胺类化合物(13a-j),并通过 1HNMR、13CNMR 和质谱数据进行了证实。此外,以依托泊苷为标准参照物,采用 MTT 法检测了新制备的 13a-j 化合物对四种人类癌细胞系(包括 MCF-7 &、MDA MB-231(人类乳腺癌)、A549(人类肺癌)和 DU-145(人类前列腺癌))的体外抗癌活性。这些结果表明,大多数衍生物都显示出了极佳至中等程度的抗癌活性。在五种化合物中,13a、13b、13c、13d 和 13e 具有显著的标准活性。其中一个化合物 13a 表现出了极佳的活性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Rational design, synthesis, and anticancer evaluation of amide derivatives of Pyridin3-yl)imidazo[2,1-b][1,3,4]thiadiazole linked 1,3,4-oxadiazoles

Rational design, synthesis, and anticancer evaluation of amide derivatives of Pyridin3-yl)imidazo[2,1-b][1,3,4]thiadiazole linked 1,3,4-oxadiazoles

A new series of amides of pyridin-3-yl)imidazo[2,1-b][1,3,4]thiadiazoles (13a-j) have been developed and confirmed by 1HNMR, 13CNMR and mass spectral data. Further, in the vitro anticancer activity of newly prepared compounds 13a-j was examined against four human cancer cell lines including MCF-7 & MDA MB-231 (human breast cancer), A549 (human lung cancer) and DU-145 (human prostate cancer) by employing the MTT assay, and using etoposide as a standard reference. These results indicated that the most of the derivatives displayed excellent to moderate anticancer activity. Among the five compounds 13a, 13b, 13c, 13d and 13e demonstrated remarkable activity as standard. One of the compounds 13a displayed excellent activity.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Chemical Data Collections
Chemical Data Collections Chemistry-Chemistry (all)
CiteScore
6.10
自引率
0.00%
发文量
169
审稿时长
24 days
期刊介绍: Chemical Data Collections (CDC) provides a publication outlet for the increasing need to make research material and data easy to share and re-use. Publication of research data with CDC will allow scientists to: -Make their data easy to find and access -Benefit from the fast publication process -Contribute to proper data citation and attribution -Publish their intermediate and null/negative results -Receive recognition for the work that does not fit traditional article format. The research data will be published as ''data articles'' that support fast and easy submission and quick peer-review processes. Data articles introduced by CDC are short self-contained publications about research materials and data. They must provide the scientific context of the described work and contain the following elements: a title, list of authors (plus affiliations), abstract, keywords, graphical abstract, metadata table, main text and at least three references. The journal welcomes submissions focusing on (but not limited to) the following categories of research output: spectral data, syntheses, crystallographic data, computational simulations, molecular dynamics and models, physicochemical data, etc.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信